On Monday, Shares of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), lost -0.25% to $63.50.
Teva Pharmaceutical Industries Ltd., declared that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s supplemental new drug application (sNDA) for ProAir RespiClick (albuterol sulfate) Inhalation Powder for the treatment or prevention of bronchospasm in patients 4 to 11 years of age with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm (EIB).
ProAir RespiClick was approved by the FDA in March 2015 for the treatment or prevention of bronchospasm in patients 12 years of age and older with reversible obstructive airway disease and for the prevention of EIB. ProAir RespiClick is the only multi-dose, breath-activated short-acting beta-agonist (SABA) inhaler available to patients in the U.S. It differs from other presently available rescue inhalers as it utilizes breath-activated technology that enables patients to breathe in to receive a measured dose of the medicine, eliminating the need for hand-breath coordination during inhalation.
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic, specialty, and other pharmaceutical products worldwide. The company operates in two segments, Generic Medicines and Specialty Medicines.
Shares of Two Harbors Investment Corp (NYSE:TWO), declined -0.27% to $9.40, during its last trading session.
Two Harbors Investment Corp., is planned to present at an forthcoming investor conference sponsored by JMP Securities. Two Harbors’ President and Chief Executive Officer, Thomas Siering, and Chief Investment Officer, William Roth, will speak at the JMP Securities Financial Services and Real Estate Conference being held on Monday, September 21, 2015 at The St. Regis in New York, New York. The presentation will comprise a negotiation of the company’s business fundamentals and investment strategy.
Two Harbors Investment Corp. operates as a real estate investment trust (REIT) that focuses on investing in, financing, and managing residential mortgage-backed securities (RMBS), residential mortgage loans, mortgage servicing rights, commercial real estate debt and related assets, and other financial assets.
At the end of Monday’s trade, Shares of KAR Auction Services Inc (NYSE:KAR), lost -0.90% to $36.40.
Insurance Auto Auctions, Inc. (IAA), a business unit of KAR Auction Services (KAR) and the leading live and live-online salvage auto auction company, declared that Tim O’Day will join the company as Senior Vice President of Finance reporting to John Kett, Chief Executive Officer and President.
With almost thirty years of experience in finance, operations, and general administration, O’Day has a combination of big company, start up and high growth business experience. Most recently O’Day worked for nine years as COO and then CFO for MedSpeed, the leading national healthcare transportation and logistics provider. Preceding to MedSpeed, O’Day founded and ran a B2B internet technology company, was president of a regional special event company, CFO of an equipment rental chain, and director of finance for a national auto glass company. He started his career at Abbott Laboratories, first in a administration training program followed by various financial administration positions in corporate and in the field. O’Day earned his Bachelor of Science degree in business from Indiana University.
“I am excited to work with Tim and further accelerate IAA’s strong momentum,” said John Kett, IAA’s chief executive officer and president. “Tim’s broad background of financial success combined with his operational and logistics experience will be noteworthyassets to the IAA organization in addition to KAR Auction Services. I look forward to him joining the executive team as we continue to grow and expand the IAA organization.”
KAR Auction Services, Inc., together with its auxiliaries, provides vehicle auction services in North America. It operates in three segments: ADESA Auctions, IAA, and AFC. The ADESA Auctions segment offers whole car auctions and related services to the vehicle remarketing industry through online auctions and auction facilities.
Finally, DENTSPLY International Inc. (NASDAQ:XRAY), ended its last trade with 1.96% gain, and closed at $53.62.
DENTSPLY International, declared that Chris Clark, President and Chief Financial Officer, will be presenting at the Robert W. Baird 2015 Healthcare Conference at the New York Palace Hotel in New York City on Wednesday, September 9, 2015.
DENTSPLY International Inc. is a leading manufacturer and distributor of dental and other consumable medical device products. The Company believes it is the world`s largest manufacturer of consumable dental products for the professional dental market. For over 115 years, DENTSPLY`s commitment to innovation and professional partnershiphas improved its portfolio of branded consumables and small equipment. Headquartered in the United States, the Company has global operations with sales in more than 120 countries. Visit www.dentsply.com for more information about DENTSPLY and its products.
DENTSPLY International Inc. designs, develops, manufactures, and markets various consumable dental products for the professional dental market in the United States and internationally. The company provides dental consumable products, counting dental supplies and devices, such as dental anesthetics, prophylaxis paste, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride; and small equipment products comprising dental handpieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
